Neurones (NRO) - Total Liabilities
Based on the latest financial reports, Neurones (NRO) has total liabilities worth €284.16 Million EUR (≈ $332.22 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore NRO net asset momentum to track the company's year-over-year net asset growth rate.
Neurones - Total Liabilities Trend (2000–2025)
This chart illustrates how Neurones's total liabilities have evolved over time, based on quarterly financial data. See Neurones free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Neurones Competitors by Total Liabilities
The table below lists competitors of Neurones ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Standard Lithium Ltd
NYSE MKT:SLI
|
USA | $33.74 Million |
|
Star Cement Limited
NSE:STARCEMENT
|
India | Rs13.65 Billion |
|
Luoniushan Co Ltd
SHE:000735
|
China | CN¥4.97 Billion |
|
AirAsia X Bhd
KLSE:5238
|
Malaysia | RM42.57 Billion |
|
Sinosteel Anhui Tianyuan Technology Co Ltd
SHE:002057
|
China | CN¥1.71 Billion |
|
T1 Energy Inc.
NYSE:TE
|
USA | $1.24 Billion |
|
CGN Nuclear Technology Development Co Ltd
SHE:000881
|
China | CN¥4.48 Billion |
|
CureVac NV
F:5CV
|
Germany | €267.39 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Neurones's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NRO company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Neurones's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Neurones (2000–2025)
The table below shows the annual total liabilities of Neurones from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €284.16 Million ≈ $332.22 Million |
-1.85% |
| 2024-12-31 | €289.52 Million ≈ $338.48 Million |
+8.70% |
| 2023-12-31 | €266.34 Million ≈ $311.38 Million |
+10.68% |
| 2022-12-31 | €240.63 Million ≈ $281.33 Million |
+11.97% |
| 2021-12-31 | €214.90 Million ≈ $251.25 Million |
+12.62% |
| 2020-12-31 | €190.83 Million ≈ $223.10 Million |
+4.38% |
| 2019-12-31 | €182.82 Million ≈ $213.73 Million |
+19.35% |
| 2018-12-31 | €153.18 Million ≈ $179.08 Million |
+6.64% |
| 2017-12-31 | €143.64 Million ≈ $167.93 Million |
-2.40% |
| 2016-12-31 | €147.18 Million ≈ $172.06 Million |
+8.66% |
| 2015-12-31 | €135.45 Million ≈ $158.35 Million |
+26.24% |
| 2014-12-31 | €107.29 Million ≈ $125.44 Million |
+3.66% |
| 2013-12-31 | €103.51 Million ≈ $121.01 Million |
+9.44% |
| 2012-12-31 | €94.58 Million ≈ $110.57 Million |
+9.54% |
| 2011-12-31 | €86.34 Million ≈ $100.94 Million |
+25.79% |
| 2010-12-31 | €68.64 Million ≈ $80.24 Million |
+12.94% |
| 2009-12-31 | €60.77 Million ≈ $71.05 Million |
-11.57% |
| 2008-12-31 | €68.72 Million ≈ $80.35 Million |
+38.59% |
| 2007-12-31 | €49.59 Million ≈ $57.97 Million |
+18.79% |
| 2006-12-31 | €41.74 Million ≈ $48.80 Million |
+38.25% |
| 2005-12-31 | €30.20 Million ≈ $35.30 Million |
+6.44% |
| 2004-12-31 | €28.37 Million ≈ $33.16 Million |
+21.65% |
| 2003-12-31 | €23.32 Million ≈ $27.26 Million |
-5.82% |
| 2002-12-31 | €24.76 Million ≈ $28.94 Million |
-6.66% |
| 2001-12-31 | €26.52 Million ≈ $31.01 Million |
+34.36% |
| 2000-12-31 | €19.74 Million ≈ $23.08 Million |
-- |
About Neurones
Neurones S.A. provides infrastructure, application, and consulting services in France. The company offers cloud, infrastructure management, DevOps, cybersecurity, user support, IT service management, information system governance, and automation services. It also provides digital, UX/UI, agile, devOps, mobility, and data; SAP integration and outsourcing content management, business process manage… Read more